Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FCMXG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on August 6, 2025, for the supply of Jakafi 10 mg tablets in a quantity of 60 units. This firm fixed-price delivery order, valued at $12,115.65, represents a continuation of pharmaceutical product distribution under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation and specifies Park Ridge, Illinois as the place of performance, with an ultimate completion date of August 7, 2025. Jakafi is a prescription medication used in the treatment of certain blood disorders and myelofibrosis, indicating this delivery supports the pharmaceutical supply needs of military health facilities.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, maintains a significant single-award IDC with the DLA under the SPE2DB program valued at $499.999 billion through November 2026. This IDC enables the agency to issue firm fixed-price delivery orders for an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare sites worldwide. The company's established track record with federal agencies and specialized pharmaceutical distribution capabilities position it as a critical supplier in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FCMXG?
SPE2DB25FCMXG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FCMXG worth?
The government has obligated $12,116 on SPE2DB25FCMXG.
Is contract SPE2DB25FCMXG an order under another contract?
Yes. SPE2DB25FCMXG is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMXG competed?
The extent of competition for SPE2DB25FCMXG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award